Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor

Journal of Vascular Surgery

Volumn 21, Issue 2, 1995, Pages 314-325

  Bauters, Christophe ^a   Asahara, Takayuki ^a   Zheng, Lu P ^a   Takeshita, Satoshi ^a   Bunting, Stuart ^a   Ferrara, Napoleone ^a   Symes, James F ^a   Isner, Jeffrey M ^a  

^a Boston ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT PROTEIN; VASCULOTROPIN;

ANGIOGENESIS; ANGIOGRAPHY; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CAPILLARY DENSITY; CONTROLLED STUDY; DRUG EFFECT; INTRAVENOUS DRUG ADMINISTRATION; LEG BLOOD FLOW; LIMB ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL;

ANIMAL; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CAPILLARIES; COLLATERAL CIRCULATION; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FEASIBILITY STUDIES; FEMORAL ARTERY; HEPARIN; HINDLIMB; ILIAC ARTERY; INJECTIONS, INTRAVENOUS; ISCHEMIA; MALE; MUSCLE FIBERS; MUSCLE, SKELETAL; NEOVASCULARIZATION, PATHOLOGIC; RABBITS; REGIONAL BLOOD FLOW; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028815417     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-5214(95)70272-5     Document Type: Article

References (31)

1. Enhanced revascularization of the ischemic limb by angiogenic therapy
2. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose response effect of basic fibroblast growth factor
3. Therapeutic angiogenesis: a single intra-arterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hindlimb model
4. The vascular endothelial growth factor family of polypeptides
5. 2-macroglobulin and the binding is inhibited by heparin
6. A persistent hindlimb ischemia model in the rabbit
7. Purification and cloning of vascular endothelial growth factor secreted by pituitary follicolostellate cells
8. Validation of a Doppler wire for intravascular measurements of coronary artery flow velocity
9. Can an intracoronary Doppler wire accurately measure changes in coronary blood flow velocity?
10. Validation of volumetric flow measurements by means of a Doppler-tipped coronary angioplasty guide wire
11. Combined physiologic and anatomic assessment of percutaneous revascularization using a Doppler guidewire and ultrasound catheter
12. Digital radiographic assessment of coronary arterial geometric diameter and videodensitometric cross-sectional area
13. Myocardial angiogenesis and coronary perfusion in left ventricular pressure-overload hypertrophy in the young lamb: evidence for inhibition with chronic protamine administration
14. The effect of long-term vasodilation on capillary growth and performance in rabbit heart and skeletal muscle
15. Angiogenesis
16. An investigation of arterial insufficiency in rat hindlimb. A combined 31P-n.m.r. and blood flow study
17. Heparin accelerates coronary collateral development in a porcine model of coronary artery occlusion
18. The binding of vascular endothelial growth factor to its receptors is dependent on cell-surface associated heparin-like molecules
19. Improvement of treadmill capacity and collateral circulation as a result of exercise with heparin pretreatment in patients with effort angina
20. Angiogenic effects of low molecular weight heparin in patients with stable coronary artery disease: a pilot study
21. Heparin promotes the formation of extracardiac to coronary anastomoses in a canine model
22. Heparin protects basic and acidic FGF from inactivation
23. Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparinase and heparin-like molecules
24. Heparin stimulation of plasminogen activator secretion by macrophage-like cell line RAW264.7: role of the scavenger receptor
25. Stimulation by heparin with plasmin-mediated conversion of single chain to two-chain urokinase-type plasminogen activator
26. Coronary collateral blood flow does not increase after heparin administration in the pig
27. One systemic administration of transforming growth factor ß1 reverses age or glucocorticoid-impaired wound healing
28. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms
29. Physiologic assessment of angiogenesis induced by a single intra-arterial bolus of vascular endothelial growth factor in the rabbit ischemic hindlimb
30. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
31. Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart